International Diabetes and Obesity Conference

Agendra of IDOC

img img

Our Agenda

img

-: First Day :-

31st May 2024

01

31 May 2024

08:45 - 09:00

Opening remarks

Dr. Ihab El Tayeb
President

01

Moderators

Dr. Mahar Jallo, Dr. Layla Al Shahrabani, Dr. Jyothish George

--
02

09:00AM - 09:20AM

Diabesity, the largest epidemic in history?

Dr. Adel Al Sisi
03

09:20AM - 09:40AM

Earlier intervention and expanding treatment options: can oral semaglutide bring the change?

Dr. Satendra Kumar Multani
04

09:40AM - 10:00AM

How much technology is needed in type 2 diabetes?

Dr. Julia Mader
05

10:00AM - 10:30AM

Ceremony

--
06

10:30AM - 10:50AM

Falak Tayyeb: a new ecosystem of support for diabetic Patients.

Dr. Asiya Nabi
07

10:50AM - 11:10AM

A new Era in the management of CKD and the role of Dapagliflozin.

Dr. Pardeep Krishnan
08

11:10AM - 11:25AM

Panel discussion

--
09

11:25AM - 11:35AM

Coffee Break

--

01

Moderators

Dr. Satandra Kumar, Dr. Julia Mader, Dr. Zara Sater

--
02

11:40AM - 12:00PM

Evolving Role of Finerenone in the Management of CKD in T2 D

Dr. Ossama Barakat
03

12:00PM - 12:20AM

PCSK9 inhibitors a game changer in dyslipidemia management.

Dr. Hassan Tamimi
04

12:20PM - 12:40PM

Oral dpp4 inhibitors is hype or hope?

Dr. Anil kumar
05

12:40PM - 12:55PM

Panel discussion

--
06

01:55PM - 02:30PM

Friday Prayer and Lunch

--

-: Second Day :-

1st June 2024

01

Moderators

Dr. Sarah Alam, Dr. Aswin Panakajakshan

--
02

09:00AM - 09:20AM

Normo calcemic hyperparathyroidism

Dr. Bachar Neamat
03

09:20AM - 09:40AM

Checkpoint inhibitors and endocrine diseases

Dr. Olga Fedorova
04

09:40AM -10:00AM

Diagnosis and Management of Thyroid nodules

Dr. Belma Buturovic
05

10:00AM - 10:20AM

Tirzepatide approved for weight loss

--
06

10:20AM - 10:40AM

Diabetes remission utopia or reality?

Dr. Mahir Khalil Jallo
07

10:40AM - 10:55AM

Panel discussion

--
08

10:55AM - 11:05AM

Coffee Break

--

01

Moderators

Dr. Apsia Ruhi, Dr. Idrees Mubarik

--
02

11:05AM - 11:25PM

The importance of treating beyond LDL-c in Diabetic Patients.

Dr. Ihab El Tayeb
03

11:25AM - 11:45AM

Triple protection of Empagliflozin across the cardiorenal metabolic syndromes

Dr. Abdul Jabbar
04

11:45AM - 12:05PM

Cardiometabolic approach to management of T2D: current evidence for GLP 1-RA in patients with ASCVD

Dr. Ali Dibbiat
05

12:05PM - 12:25PM

Challenges in Dyslipidemia Management.

Dr. Sundar Kumar
06

12:25PM - 12:45PM

Time in the range:the missing piece to glucose control.

Dr. El Elamin Abdelgadir
06

12:45PM - 01:05PM

Emerging Therapies for Obesity 2024.

Dr. Zara Sater
06

01:05PM - 01:15PM

Panel Discussion

--
06

01:15PM - 01:45PM

Lunch Time

--

01

Moderators

Dr. Apsia Ruhi, Dr. Ihab El Tayeb

--
02

01:45PM - 02:05PM

Post-bariatric hypoglycemia

Dr. Haitham Sawalmeh
03

02:05PM - 02:25PM

Osteoporosis management from a rheumatological point of view

Dr. Ahmed Negm
04

02:25PM - 04:15PM

Endocrine Grand round (11 unique cases)

Dr. Sarah Alam
Dr. Yosra Hasni
Dr. Apsia Ruhi
Dr. Doaa El wasly
Dr. El ameen Abdelgadir
Dr. Aswin Panakajakshan
05

04:15PM - 04:30PM

Panel discussion

--

01

Moderators

Dr. Yosra Hasni, Dr. Zara Sater

--
02

04:30PM - 04:50PM

Diabetes insipidus renaming

Dr. Idrees Mubarik
03

04:50PM - 05:10PM

Obesity and Precision Medicine

Dr. Ihab El Tayeb
04

05:10PM - 05:25PM

Panel discussion

--
05

05:25PM

Closing

--
Download Agenda